A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
Public ClinicalTrials.gov record NCT05238597. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled Clinical Trial Evaluating the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this trial are to assess the safety, tolerability and efficacy of A197 ophthalmic solution in comparison to a vehicle control in the treatment of subjects with Dry Eye Disease.
Study identification
- NCT ID
- NCT05238597
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 25, 2022 (Actual)
- Primary completion
- Jan 24, 2023 (Actual)
- Completion
- Jan 24, 2023 (Actual)
- Last update posted
- May 16, 2023
2022 – 2023
United States locations
- U.S. sites
- 24
- U.S. states
- 11
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aramis Site 113 | Birmingham | Alabama | 35233 | — |
| Aramis Site 121 | Garden Grove | California | 92843 | — |
| Aramis Site 120 | Glendale | California | 95817 | — |
| Aramis Site 106 | Long Beach | California | 90805 | — |
| Aramis Site 124 | Los Angeles | California | 90013 | — |
| Aramis Site 107 | Murrieta | California | 92562 | — |
| Aramis Site 102 | Newport Beach | California | 92663 | — |
| Aramis Site 116 | Petaluma | California | 94954 | — |
| Aramis Site 109 | Rancho Cordova | California | 95670 | — |
| Aramis Site 101 | Delray Beach | Florida | 33484 | — |
| Aramis Site 112 | Jacksonville | Florida | 32204 | — |
| Aramis Site 117 | Largo | Florida | 33773 | — |
| Aramis Site 118 | Edgewood | Kentucky | 41017 | — |
| Aramis Site 114 | Kansas City | Missouri | 64111 | — |
| Aramis Site 111 | St Louis | Missouri | 63128 | — |
| Aramis Site 108 | Las Vegas | Nevada | 89119 | — |
| Aramis Site 110 | Garner | North Carolina | 27529 | — |
| Aramis Site 122 | Shelby | North Carolina | 28150 | — |
| Aramis Site 119 | Mason | Ohio | 45040 | — |
| Aramis Site 123 | Cranberry Township | Pennsylvania | 16066 | — |
| Aramis Site 115 | Goodlettsville | Tennessee | 37072 | — |
| Aramis Site 103 | Memphis | Tennessee | 38119 | — |
| Aramis Site 104 | Lakeway | Texas | 78738 | — |
| Aramis Site 105 | San Antonio | Texas | 78215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05238597, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05238597 live on ClinicalTrials.gov.